Sage Therapeutics
SAGE
#7401
Rank
NZ$0.97 B
Marketcap
NZ$15.54
Share price
0.00%
Change (1 day)
11.22%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -NZ$0.51 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are NZ$70.41 Million. In 2024 the company made an earning of -NZ$0.72 Billion, an increase over its 2023 earnings that were of -NZ$0.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.51 Billion-29.1%
2024 -NZ$0.72 Billion-26.01%
2023 -NZ$0.97 Billion1.63%
2022 -NZ$0.96 Billion16.36%
2021 -NZ$0.82 Billion-175.55%
2020 NZ$1.08 B-189.1%
2019 -NZ$1.22 Billion82.43%
2018 -NZ$0.67 Billion38.04%
2017 -NZ$0.49 Billion69.9%
2016 -NZ$0.29 Billion68.25%
2015 -NZ$0.17 Billion179.48%
2014 -NZ$60.53 Million84.98%
2013 -NZ$32.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-NZ$84.9 Million-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-NZ$0.11 Billion-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$0.91 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eagle Pharmaceuticals
EGRX
NZ$63.82 M-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA